menu ☰
menu ˟

FDA grants full approval to Blincyto for acute lymphoblastic leukemia

12 Jul 2017
The FDA approved a supplemental biologics license application for blinatumomab, according to the agent’s manufacturer.The agency previously granted accelerated approval to blinatumomab (Blincyto, Amgen) for treatment of children and adults with rel...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.